跳至主要内容
临床试验/NCT00338234
NCT00338234已完成不适用

Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients, Role of Hepcidin

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
153
试验地点
1
主要终点
Functional iron deficiency

研究概览

简要总结

Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation.

详细描述

Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation. The latter is known to interfere with iron metabolism, inducing iron storage instead of using it for hemoglobin synthesis. The discover of a new regulatory hormone of iron metabolism, hepcidin, may help us to better understand the link between inflammation and iron functional deficit. The aim of our study is to observe the variation of usual iron metabolism biological markers and of hepcidin, in order to define the better marker of iron loss in these clinical situations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 88 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Anemia (haemoglobin < 10 g/dL)
  • Hospitalization in ICU for an expected duration of 7 days or more
  • Or, day one post cardiac surgery

排除标准

  • Chronic anemia (Hb < 9 g/dL for more than one month before hospitalization)
  • Iron metabolism disease

结局指标

主要结局

Functional iron deficiency

时间窗: during the study

次要结局

  • fatigue assessed by the MFI20 score for cardiac surgery patients(at one day,at seven days and at 28 days)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验